dr. dorff on the status of immunotherapy in prostate cancer
Published 5 years ago • 127 plays • Length 1:42Download video MP4
Download video MP3
Similar videos
-
0:19
copy of dr. dorff on choosing between therapies in nonmetastatic crpc
-
1:10
dr. dorff on current agents for patients with mcrpc
-
1:32
dr. higano on the state of immunotherapy in prostate cancer
-
0:57
dr. dorff on choosing between therapies in nonmetastatic crpc
-
1:24
dr. dorff discusses the use of parp inhibitors in prostate cancer
-
1:03:59
immunotherapy -dr. tanya dorff
-
1:38
dr. dorff on role of chemotherapy in mcrpc
-
0:40
tanya dorff, md, on the future of cellular immunotherapy versus checkpoint inhibition in mpc
-
1:37
dr. slovin on the future of immunotherapy in prostate cancer
-
1:09
dr. gerritsen on shortcomings of immunotherapy in prostate cancer
-
1:03
dr. slovin on the role of immunotherapy for prostate cancer
-
1:04
dr. tanya dorff on the future of car t cell therapy for prostate cancer | asco22
-
1:55
meet our doctors: tanya dorff, m.d. | city of hope
-
2:17
impact of immunotherapy on the treatment of prostate cancer
-
1:38
dr. slovin on the challenges of immunotherapy in prostate cancer
-
1:11
dr. oh on immunotherapies for prostate cancer
-
1:03
dr. slovin on approaches of immunotherapy in prostate cancer
-
1:23
tanya dorff, md, on the role of chemotherapy in mcrpc patients who have failed prior therapies
-
2:02
dr. dorff on sequencing in metastatic castration-resistant prostate cancer